PureTech Health PLC - Asset Resilience Ratio

Latest as of March 2026: 4.64%

PureTech Health PLC (PRTC) has an Asset Resilience Ratio of 4.64% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of PureTech Health PLC to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$24.83 Million

Cash + Short-term Investments

Total Assets

$534.71 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2012–2025)

This chart shows how PureTech Health PLC's Asset Resilience Ratio has changed over time. See PRTC equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down PureTech Health PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PRTC stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$24.83 Million	4.64%
Total Liquid Assets	$24.83 Million	4.64%

Asset Resilience Insights

Limited Liquidity: PureTech Health PLC maintains only 4.64% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

PureTech Health PLC Industry Peers by Asset Resilience Ratio

Compare PureTech Health PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for PureTech Health PLC (2012–2025)

The table below shows the annual Asset Resilience Ratio data for PureTech Health PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.64%	$24.83 Million	$534.71 Million	-9.74pp
2024-12-31	14.38%	$86.67 Million	$602.63 Million	-5.23pp
2023-12-31	19.61%	$136.06 Million	$693.97 Million	-8.89pp
2022-12-31	28.50%	$200.23 Million	$702.65 Million	+28.63pp
2021-12-31	-0.14%	$-1.28 Million	$946.01 Million	+0.04pp
2020-12-31	-0.17%	$-1.70 Million	$989.99 Million	-3.37pp
2019-12-31	3.20%	$30.09 Million	$941.18 Million	-27.10pp
2018-12-31	30.29%	$133.83 Million	$441.76 Million	-4.14pp
2017-12-31	34.43%	$117.03 Million	$339.85 Million	-39.01pp
2016-12-31	73.44%	$219.41 Million	$298.75 Million	+18.42pp
2015-12-31	55.02%	$179.78 Million	$326.75 Million	+54.51pp
2014-12-31	0.51%	$1.17 Million	$228.03 Million	-10.41pp
2013-12-31	10.92%	$1.83 Million	$16.77 Million	+4.79pp
2012-12-31	6.13%	$1.18 Million	$19.18 Million	--

pp = percentage points

About PureTech Health PLC

NASDAQ:PRTC USA Biotechnology

Market Cap

$421.36 Million

Market Cap Rank

#13331 Global

#3178 in USA

Share Price

$17.31

Change (1 day)

+2.64%

52-Week Range

$14.50 - $19.84

All Time High

$64.00